Cardlytics, Inc.
Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: Cardlytics, Inc. |
Ticker: | Ticker: CDLX |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX). The investigation concerns whether Cardlytics and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On August 7, 2024, Cardlytics reported its financial results for the second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating “our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives.” The Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors. On this news, the price of Cardlytics shares declined by $3.94 per share, or approximately 57.1%, from $6.90 per share on August 7, 2024 to close at $2.96 on August 8, 2024.
On August 7, 2024, Cardlytics reported its financial results for the second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating “our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives.” The Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors. On this news, the price of Cardlytics shares declined by $3.94 per share, or approximately 57.1%, from $6.90 per share on August 7, 2024 to close at $2.96 on August 8, 2024.